期刊
CLINICAL LYMPHOMA & MYELOMA
卷 6, 期 6, 页码 496-499出版社
CIG MEDIA GROUP, LP
DOI: 10.3816/CLM.2006.n.033
关键词
B-cell lymphoma; CD20; chemotherapy; rituximab; splenectomy
类别
We describe the case of a 61-year-old patient with refractory splenic marginal zone lymphoma and secondary autoimmune hemolytic anemia, both successfully treated with rituximab. This case demonstrates that rituximab monotherapy might also be a valid therapeutic approach in marginal zone lymphoma and autoimmune hemolytic anemia after failure of first-line treatment. Maintenance therapy, although expensive, could be useful to improve event-free survival in patients with unfavorable clinical behavior.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据